cdmo.directory
← Compare landing

BioVectra vs Charles River Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/biovectra/criver

CategoryBioVectraCharles River Laboratories
Listed sitecdmoboth
SummaryNorth American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
Services
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Formulation Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Microbial Fermentation
  • Downstream Processing
  • Upstream Processing
  • Recombinant Protein Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • mRNA Manufacturing
  • Cell-Line Development
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
Modalities
  • Small Molecule
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Gene Therapy
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
Locations
  • Headquarters, Charlottetown, Prince Edward Island, Canada
  • Research & Development, Charlottetown, Prince Edward Island, Canada
  • New API Facility, Charlottetown, Prince Edward Island, Canada
  • Dedicated Facility, Charlottetown, Prince Edward Island, Canada
  • Large Scale Biomanufacturing Facility, Windsor, Nova Scotia, Canada
  • Research & Development, Prince Edward Island, PE, Canada
  • Headquarters, Prince Edward Island, PE, Canada
  • New API Facility, Prince Edward Island, PE, Canada
  • Dedicated Natural Extraction Facility, Prince Edward Island, PE, Canada
  • Headquarters, United States
  • North America, North America, USA/Canada
  • Europe, Europe, Multiple
  • Asia, Asia, Multiple
  • North America, North America
  • Europe, Europe
  • Asia, Asia
CertificationsData not yet provided.
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.